Finance News – 3Sbio
What is your interest today?
Bitcoin
Crypto
Btc
Stocks
Shares
Tariffs
Stock
Investors
Ceo
Stock Market
Crypto Assets
Ethereum
Cryptocurrency
Price
Markets
Xrp
Eth
Etf
Bse
Earnings
Ipo
Stablecoin
Investment
Blockchain
Revenue
Solana
Index
Trade
Sec
Inflation
Interest Rates
Token
Wall Street
Sensex
Coinbase
Treasury
Federal Reserve
Nasdaq
Traders
Profit
Nse
China
Bse Sensex
Nifty
Sp 500
Investor
Gold
Tesla
Company
Economy
Ondo Finance
Parliament
Wood Group
Rate Hedged
Eu Us Tariff War
Cboe One Feed
Smart Data Group
Acx Token
Green Thumb Industries
Trustware
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Investopedia • May 20, 2025
Pfizer Inks Up to $6B Deal to Market 3SBio's Cancer Drug Outside China
Pfizer has entered into an agreement potentially valued at $6 billion to distribute a cancer medication developed by 3SBio in international markets beyond China.
Read Full Article →